About this trial

This trial is enrolling 50 individuals with acute spinal cord injuries (within 48 hours since injury) to test the effect of a drug (calcitonin) on neuropathic pain. Calcitonin, which reduces calcium levels in the body, has previously been shown to be effective in the management of acute pain following amputation, vertebral fractures and other neuropathic conditions. If included, participants will receive an injection under the skin of either: 1) calcitonin; or 2) placebo. The injections will be given every day for 2 weeks. Final pain assessments will be performed after 9 months.